Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making

Breast cancer is the most common cancer in women, impacting 2.1 million women each year. The number of publications on BC is much higher than for any other type of tumor, as well as the number of clinical trials. One of the consequences of all this information is reflected in the number of approved...

Descripción completa

Detalles Bibliográficos
Autor principal: Tilli, Tatiana Martins
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703478/
https://www.ncbi.nlm.nih.gov/pubmed/34945820
http://dx.doi.org/10.3390/jpm11121348
_version_ 1784621473224196096
author Tilli, Tatiana Martins
author_facet Tilli, Tatiana Martins
author_sort Tilli, Tatiana Martins
collection PubMed
description Breast cancer is the most common cancer in women, impacting 2.1 million women each year. The number of publications on BC is much higher than for any other type of tumor, as well as the number of clinical trials. One of the consequences of all this information is reflected in the number of approved drugs. This review aims to discuss the impact of technological advances in the diagnosis, treatment and decision making of breast cancer and the prospects for the next 10 years. Currently, the literature has described personalized medicine, but what will the treatment be called for in the coming years?
format Online
Article
Text
id pubmed-8703478
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87034782021-12-25 Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making Tilli, Tatiana Martins J Pers Med Review Breast cancer is the most common cancer in women, impacting 2.1 million women each year. The number of publications on BC is much higher than for any other type of tumor, as well as the number of clinical trials. One of the consequences of all this information is reflected in the number of approved drugs. This review aims to discuss the impact of technological advances in the diagnosis, treatment and decision making of breast cancer and the prospects for the next 10 years. Currently, the literature has described personalized medicine, but what will the treatment be called for in the coming years? MDPI 2021-12-10 /pmc/articles/PMC8703478/ /pubmed/34945820 http://dx.doi.org/10.3390/jpm11121348 Text en © 2021 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tilli, Tatiana Martins
Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
title Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
title_full Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
title_fullStr Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
title_full_unstemmed Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
title_short Precision Medicine: Technological Impact into Breast Cancer Diagnosis, Treatment and Decision Making
title_sort precision medicine: technological impact into breast cancer diagnosis, treatment and decision making
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703478/
https://www.ncbi.nlm.nih.gov/pubmed/34945820
http://dx.doi.org/10.3390/jpm11121348
work_keys_str_mv AT tillitatianamartins precisionmedicinetechnologicalimpactintobreastcancerdiagnosistreatmentanddecisionmaking

Ejemplares similares